Found: 22
Select item for more details and to access through your institution.
Anti-PD-1: When to Stop Treatment.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 7, p. 905, doi. 10.1007/s11912-022-01264-6
- By:
- Publication type:
- Article
Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.
- Published in:
- Current Oncology, 2011, v. 18, n. 5, p. e256, doi. 10.3747/co.v18i5.789
- By:
- Publication type:
- Article
Small bowel metastases from melanoma : does videocapsule provide additional information after FDG positron emission tomography?
- Published in:
- Acta Gastro-Enterologica Belgica, 2012, v. 75, n. 2, p. 219
- By:
- Publication type:
- Article
Ethical Aspects of Genetic Counseling in Familial Breast and Ovarian Cancer<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1997, v. 833, n. 1, p. 170, doi. 10.1111/j.1749-6632.1997.tb48604.x
- By:
- Publication type:
- Article
O1.05 AXITINIB, A SELECTIVE VEGFR-1,-2,-3 TYROSINE KINASE INHIBITOR, INHIBITS TUMOR GROWTH AND INCREASES INFILTRATION OF IMMUNE CELLS IN AN INTRACRANIAL MELANOMA MOUSE MODEL.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii2, doi. 10.1093/neuonc/nou174.5
- By:
- Publication type:
- Article
P01.11 ATF4 AS A MEDIATOR OF RESISTANCE TO TARGETED THERAPY IN HIGH-GRADE GLIOMAS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii29, doi. 10.1093/neuonc/nou174.104
- By:
- Publication type:
- Article
P16.09 VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii79, doi. 10.1093/neuonc/nou174.305
- By:
- Publication type:
- Article
O10.07 RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii24, doi. 10.1093/neuonc/nou174.88
- By:
- Publication type:
- Article
Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine.
- Published in:
- 2008
- By:
- Publication type:
- Letter
The predictive and prognostic significance of cell‐free DNA concentration in melanoma.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 2, p. 387, doi. 10.1111/jdv.16766
- By:
- Publication type:
- Article
Vemurafenib-associated Dupuytren- and Ledderhose palmoplantar fibromatosis in metastatic melanoma patients.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2016, v. 30, n. 7, p. 1133, doi. 10.1111/jdv.13268
- By:
- Publication type:
- Article
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 1, p. 69, doi. 10.1080/0284186X.2020.1818823
- By:
- Publication type:
- Article
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 1, p. 115, doi. 10.1007/s11060-017-2629-z
- By:
- Publication type:
- Article
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 128, n. 1, p. 147, doi. 10.1007/s11060-016-2092-2
- By:
- Publication type:
- Article
Phase II study of sunitinib malate in patients with recurrent high-grade glioma.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 103, n. 3, p. 491, doi. 10.1007/s11060-010-0402-7
- By:
- Publication type:
- Article
Health-state utilities in long-term advanced melanoma survivors comparable with the general population.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 9, p. 2517, doi. 10.1007/s11136-023-03427-9
- By:
- Publication type:
- Article
An Observational Study of the First Experience with Bevacizumab for the Treatment of Patients with Recurrent High-Grade Glioma in Two Belgian University Hospitals.
- Published in:
- Journal of Oncology, 2012, p. 1, doi. 10.1155/2012/801306
- By:
- Publication type:
- Article
Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
- Published in:
- British Journal of Cancer, 2001, v. 85, n. 10, p. 1592, doi. 10.1054/bjoc.2001.2082
- By:
- Publication type:
- Article
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
- Published in:
- British Journal of Dermatology, 2014, v. 171, n. 5, p. 987, doi. 10.1111/bjd.13100
- By:
- Publication type:
- Article
Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article